OTCMKTS:RDGL Advanced Medical Isotope (RDGL) Stock Price, News & Analysis $0.05 0.00 (-1.12%) As of 08/21/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Advanced Medical Isotope Stock (OTCMKTS:RDGL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get RDGL alerts:Sign Up Key Stats Today's Range$0.05▼$0.0650-Day Range$0.05▼$0.0952-Week Range$0.05▼$0.12Volume1.11 million shsAverage Volume1.12 million shsMarket Capitalization$26.23 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. Read More Advanced Medical Isotope Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreRDGL MarketRank™: Advanced Medical Isotope scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Advanced Medical Isotope. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Advanced Medical Isotope is -5.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Advanced Medical Isotope is -5.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the float of Advanced Medical Isotope has been sold short.Short Interest Ratio / Days to CoverAdvanced Medical Isotope has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Advanced Medical Isotope has recently decreased by 18.26%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdvanced Medical Isotope does not currently pay a dividend.Dividend GrowthAdvanced Medical Isotope does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Advanced Medical Isotope this week, compared to 0 articles on an average week.Search Interest1 people have searched for RDGL on MarketBeat in the last 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Advanced Medical Isotope insiders have not sold or bought any company stock.Percentage Held by Insiders18.50% of the stock of Advanced Medical Isotope is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsAdvanced Medical Isotope has minimal institutional ownership at this time.Read more about Advanced Medical Isotope's insider trading history. Receive RDGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Advanced Medical Isotope and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RDGL Stock News HeadlinesVivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India's Nuclear Regulatory Authority for International Manufacturing CenterAugust 18, 2026 | globenewswire.comVivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - CorrectionJuly 27, 2026 | globenewswire.comA Dark Day Is Coming to AmericaKeith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift in the AI market is approaching, and time is short to prepare. Kaplan points to August 31st as a key turning point for AI investing. He argues the next phase will separate winners from losers, and reveals what he's watching instead of big names like Nvidia. | TradeSmith (Ad)Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate UpdateJuly 27, 2026 | globenewswire.comVivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™July 6, 2026 | globenewswire.comVivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® ManufacturingJune 11, 2026 | globenewswire.comVivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™June 5, 2026 | globenewswire.comVivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production SitesFebruary 17, 2026 | globenewswire.comSee More Headlines RDGL Stock Analysis - Frequently Asked Questions How have RDGL shares performed this year? Advanced Medical Isotope's stock was trading at $0.0689 at the beginning of 2026. Since then, RDGL stock has decreased by 22.9% and is now trading at $0.0531. How were Advanced Medical Isotope's earnings last quarter? Advanced Medical Isotope Corporation (OTCMKTS:RDGL) announced its earnings results on Monday, March, 30th. The company reported ($0.01) earnings per share for the quarter. The company earned $0.02 million during the quarter. How do I buy shares of Advanced Medical Isotope? Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Advanced Medical Isotope own? Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Medical Isotope investors own include MannKind (MNKD), Agenus (AGEN), APA (APA), Bionano Genomics (BNGO), Churchill Capital Corp IV (CCIV) and Canopy Growth (CGC). Company Calendar Last Earnings3/30/2026Today8/21/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:RDGL CIK1449349 Webwww.radiogel.com Phone(509) 736-4000Fax509-736-4007Employees1Year Founded2006Profitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.07 million Net Margins-3,637.37% Pretax Margin-3,636.36% Return on EquityN/A Return on Assets-144.13% Debt Debt-to-Equity RatioN/A Current Ratio48.85 Quick Ratio47.72 Sales & Book Value Annual Sales$70 thousand Price / Sales374.70 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-5.31Miscellaneous Outstanding Shares493,960,000Free Float402,581,000Market Cap$26.23 million OptionableNot Optionable Beta-0.73 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (OTCMKTS:RDGL) was last updated on 8/22/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredYour Free Report (Inside)A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | Sponsored23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredThe world's #2 gold miner is running on fumes [it has to buy]Barrick, the world's second-largest gold miner, produced 7.77 million ounces in 2010. This year, output is exp...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Advanced Medical Isotope Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Advanced Medical Isotope With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
